Clinical Trial Results: Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing standard-of-care chemotherapy with or without stereotactic body radiation therapy for oligometastatic pancreatic cancer; study terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oligometastatic Pancreatic Ductal Adenocarcinoma
• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Chemotherapy (standard of care) (Chemotherapy)
• Stereotactic Body Radiation Therapy (SBRT) (SBRT)

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2026-06-18